Vasopressin-2 receptor antagonist peptides and uses thereof
Grant
US12595288B2
Kind: B2
Apr 07, 2026
Assignee
COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES
Inventors
Nicolas Gilles, Justyna Ciolek, Laura Droctove, Bernard Maillere, Herve Nozach
Abstract
A peptide may include a sequence having 80% or more amino acid identity with the amino acid sequence of SEQ ID NO. 1, i.e., RPSX1CNLPVKPGPCX2GFFSAFYYSQKX3NKCHSFTYGGCAGNANRFSTX4EKCRRTC X5X6, wherein, X1 is the amino acid residue F or G, X2 is any amino acid residue, except a basic amino acid residue, X3 is the amino acid residue T or D, X4 is the amino acid residue I, L, or E, (i) X5 is V and X6 is G or (ii) X5 is G and X6 is V, and the amino acid located at position 39 is A. Such peptides may have various diagnostic and therapeutic uses.
CPC Classifications
C07K 14/46
A61K 38/17
C12N 15/63
G01N 33/5008
G01N 2333/72
Filing Date
2021-06-23
Application No.
18002625
Claims
14